Programme

Programme at a Glance

PRE-CONGRESS WORKSHOPS
25th July 2021
Time Pre-Congress Workshop 1
Kidney transplant immunopathology
Pre-Congress Workshop 2
Organ donation & procurement
Pre-Congress Workshop 3
Workup of potential transplant recipients
0815-0830 Course overview Course overview Course overview
0830-0900 0830 – 0915
The immune response to transplantation
Active donor detection in Spain. is there a wrong or a right way to do it? CKD burden in Asia
0900-0930 0915 – 0930
BREAK
Ancillary testing in brain death Economics of transplantation in Asia
0930-1000 0930 – 1015
Immune cells involved in transplantation rejection
Updates on donor maintenance to deliver quality organs for transplantation Optimizing potential recipients for kidney transplantation
1000-1030 COFFEE BREAK
1030-1100 1030 – 1115
Tissue typing and detection of pre-formed antibodies
Understanding refusals: what makes family consent? Evaluation of kidney transplant recipients – an overview
1100-1130 1115 – 1145
Induction therapy
Family donor conversation workshop Surgical aspects of kidney transplant recipients
1130-1200 1145 – 1200
BREAK
Consensus guideline on immunological evaluation of transplant recipients
1200-1230 Desensitisation – HLA antibodies, ABOi transplantation Managing the original kidney disease
1230-1300 Immunosuppressive drugs Pre-transplant cardiac evaluation
1300 -1400 LUNCH
1400-1430 Renal allograft histopathology: Banff Classification Bringing teams together, sharing experience Evaluation of liver transplant recipients
1430-1500 T cell mediated rejection: diagnosis and management Biological markers in organ donation and transplantation: an update Surgical aspects of liver transplant recipients
1500-1530 1500 – 1515
BREAK
HCV and HIV positive donors Pediatric renal recipient work-up
1530-1600 1515 – 1545
Antibody mediated rejection: diagnosis and management
Normothermic machine perfusion for liver allograft: current evidence What does the HLA crossmatch mean?
1600-1630 1545 – 1630
Strategies for achieving tolerance
The power of social media and how It can affect organ donation. Frailty -assessment and prognosis
1700-1830 OPENING CEREMONY

 

Congress (Day 1)
26th Jul 2021
Time PLENARIES
0830-0900 Plenary 1: Management of transplantation in the digital era
0900-0930 Plenary 2: Updates on Tregs and tolerance
0930-1000 Plenary 3: Prolonging kidney allograft survival: what works best?
1000-1030 COFFEE BREAK
1030-1230 STATE OF THE ART SYMPOSIUM (1)
  Kidney transplant Liver transplant Heart & Lung Donation & ethics
1030-1050 Donor kidney quality and long-term allograft outcome Epidemiology of non-alcoholic fatty liver and non-alcoholic steatohepatitis: implications for liver transplantation Setting up a pediatric heart transplant and MCS (mechanical circulatory support) program The Declaration of Istanbul on Organ Trafficking and Transplant Tourism 2018
1050-1110 Long-term living donor outcome: cause for concern? Role of bridging therapies in acute and acute-on-chronic liver failures mTOR Inhibitors in heart transplantation Importance of post donation care: a comparison of practices around the world.
1110-1130 Causes of death with function – what can we do to prevent it? Emerging indications for liver transplantation Pulmonary hypertension and lung transplantation Malaysia: curbing illegal overseas transplantation. should we deny recipients of free immunosuppressants?
1130-1150 Managing a second transplant De-novo malignancy post-liver transplant Bridging to lung transplantation: who, when and with what? DCD – Euthanasia, withdrawal of therapy, reintubation…where do we draw the line?
1150-1210 Trials in kidney transplantation Selection criteria for transplantation in HCC Future technology in ventricular assist devices Opting in vs opting out: which works better?
1210-1230        
1230-1400 INDUSTRY SPONSORED LUNCH SYMPOSIUM
1400-1540 ABSTRACT PRESENTATIONS
(selected oral presentations)
1540-1610 COFFEE BREAK
1610-1640 Plenary 4: Chimerism, transplant tolerance and beyond Megan Sykes
1640-1800 DEBATES and STATE OF THE ART SYMPOSIUM (2)
  Kidney - debates Liver - debates Heart & Lung Transplantation and COVID 19
1640-1720 Living donors should be incentivised
Pro:
Con:
Active drinkers should be transplanted
Pro:
Con:
Artificial intelligence in LVAD implantation
(20 mins)
COVID 19: Virology and pathogenesis
(15 mins)
Less invasive VAD Implantation
(20 mins)
SARS Coronavirus 2: Update on clinical trials
(15 mins)
1720-1800 Robotic renal transplantation vs Open renal transplantation – which is a better technique?
Robotic: Open:
Liver transplantation for liver metastasis
Pro:
Con:
Late complications following lung transplantation
(20 mins)
Clinical presentation, complications, and outcomes in solid organ transplant recipients
(25 mins)
Living related lung transplant – Japanese model
(20 mins)
Management of the transplant program in the time of COVID 19
(25 mins)

 

Congress (Day 2)
27th Jul 2021
Time PLENARIES AND REGISTRIES
0800-0830 Plenary 5: Liver transplantation in metastatic liver disease
0830-0900 Plenary 6: 50 donors p.m.p. is not a dream anymore: how did Spain do it?
0900-1000 Special Sessions: Transplant Registries
0900-0915: What can we learn from registries?
Transplant Registries in Asia
0915-0925: Singapore:
0925-0935: India:
0935-0945: Japan:
0945-0955: Korea:
0955-1000:
1000-1030 COFFEE BREAK
1030-1230 STATE OF THE ART SYMPOSIUM (3)
  Kidney transplant Liver transplant Heart & Lung Surgical aspects of kidney transplantation
1030-1050 Evolution of Banff Classification: 20 years ahead Current trends of immunosuppression in liver transplantation Organ donation innovative strategy in South East Asia (Odissea). what have we learnt? The complex living donor
1050-1110 Highly sensitized recipient: desensitization strategies-: practical approaches Acute liver failure and transplantation – indicators for poor outcome Deceased donation. should we allow donor family to meet recipients? The complex recipient
1110-1130 Management of ABMR: Current updates ABO incompatible liver transplantation Overcoming cultural barriers. is this the key to gaining consent? Role of interventional radiologist in kidney transplantation
1130-1150 Paired kidney exchange: success and challenges and lesson learnt Hepatitis B reactivation post liver transplantation Increasing demand on master education for donation & transplantation. Coping with donor complications
1150-1210 ABO incompatible renal transplantation Role of Interventional radiology post liver transplant Burnout amongst donor coordinators: is it real? When should I not proceed with kidney transplantation from a surgical perspective?
1210-1230        
1230-1400 INDUSTRY SPONSORED LUNCH SYMPOSIUM
1400-1600 STATE OF THE ART SYMPOSIUM (4)
  Transplant immunology Surgical aspects of liver transplantation Transplant infectious disease Biomarkers in transplantation
1400-1420 What is immunological risk? Advances in surgical techniques in living donor liver transplantation Asymptomatic bacteriuria post kidney transplantation: what to do Biomarkers in acute rejection
1420–1440 High resolution HLA typing in solid organ transplantation: is it necessary? Laparoscopic living donor hepatectomy: safety and efficacy Unusual infections from deceased donors Biomarkers in chronic allograft dysfunction
1440-1500 HLA mismatching and kidney transplant outcomes: what matters? Long term liver transplant outcomes Difficult fungal infections: diagnostic approaches and management Role of biomarkers in personalized Immunosuppression: are we there yet?
1500–1520 Denovo DSA: Risk factors and clinical consequences Organ preservation Latent TB: detection and management Gut microbiome in solid organ transplantation
1520–1540 Clinical relevance of non-HLA antibodies Pediatric liver transplantation Respiratory viral infections in transplant recipients Cell-free DNA and active rejection in kidney allografts
1540-1550        
1550-1620 COFFEE BREAK
1620–1800 STATE OF THE ART SYMPOSIUM (5)
  Kidney Women in transplantation Transplant immunology Post-transplant complications
1620-1640 Belatacept in kidney transplant: past and future perspectives Equity in donors and recipients in places with disparities Eplet matching in kidney transplantation Transplant-associated thrombotic microangiopathy - more than just clot and bleed
1640-1700 Optimizing mycophenolic acid exposure in kidney transplant recipients: time for target concentration intervention Equity in leadership Role of DSA monitoring post kidney transplantation Post- transplant lymphoproliferative disorders
1700-1720 mTORi with CNI as initial immunosuppression in renal transplantation Fertility and pregnancy post solid organ transplantation The influence of immunosuppressive agents on the risk of denovo DSA in solid organ transplant recipient Risk of cancer after solid organ transplant in childhood
1720-1740 T cell mediated rejection Sensitization during pregnancy: what is the impact? Targeting complement as rejection therapy Obesity and metabolic syndrome post transplantation: prevention and management
1740-1800 Advances in organ engineering Mentoring: role of WIT group The role for inhibition of the CD40-CD154 pathway in co-stimulation blockade Medication adherence

 

Congress (Day 3)
28th July 2021
Time PLENARIES
0800-0830 Plenary 7: The role of B cells in transplantation
0830-0900 Plenary 8: Experimental xenotransplantation
0900-1000 STATE OF THE ART SYMPOSIUM (6) and TRANSPLANTATION IN ASIA
  Innovation in transplantation Post-transplant complications Transplantation in Asia
0900-0920 Artificial kidneys Cardiovascular disease & dyslipldaemia in transplantation  
0920-0940 Clinical transplantation: how do we measure performance? Current strategies in post-transplant diabetes mellitus  
0940-1000 Future of research in transplantation Bone disease post transplantation: spectrum, impact, prevention and management  
1000-1030 COFFEE BREAK
1030-1230 ABSTRACT PRESENTATIONS
(selected oral presentations)
Transplantation in Asia
1230-1400 INDUSTRY SPONSORED LUNCH SYMPOSIUM
  STATE OF THE ART SYMPOSIUM (7)
  Transplantation in Asia – challenges & way forward Transplant infectious diseases  
1400-1420 Role of Vitallink in advancing transplantation in Asia CMV: Consensus on monitoring, prevention, and therapeutic updates  
1420-1440 Longest on waiting list vs fittest and shortest waiting time gets the kidney Current perspectives of BKV in transplant recipients  
1440-1500 The Spanish model: can it be implemented in Asia? Hepatitis C: When is the optimal time to treat?  
1500-1510      
1515-1600 CLOSING CEREMONY & AWARDS CEREMONY